Singapore markets closed

iX Biopharma Ltd. (42C.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.0410-0.0020 (-4.65%)
At close: 05:04PM SGT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-9,595
-9,615
-4,598
-8,234
-10,499
Depreciation & amortisation
874
929
1,060
1,054
1,049
Stock-based compensation
-450
857
1,381
997
538
Change in working capital
-149
-452
-698
-328
261
Inventory
-292
-202
-44
-348
-83
Other working capital
-7,201
-8,355
2,923
-8,905
-9,314
Other non-cash items
413
264
202
167
151
Net cash provided by operating activities
-6,564
-7,660
3,123
-8,352
-8,320
Cash flows from investing activities
Investments in property, plant and equipment
-637
-695
-200
-553
-994
Purchases of investments
-
0
-5,423
0
-
Net cash used for investing activities
704
-695
-5,623
-507
-994
Net change in cash
-5,124
-6,932
7,289
1,165
-10,140
Cash at beginning of period
10,694
12,906
5,585
4,470
14,709
Cash at end of period
5,570
5,927
12,906
5,585
4,470
Free cash flow
Operating cash flow
-6,564
-7,660
3,123
-8,352
-8,320
Capital expenditure
-637
-695
-200
-553
-994
Free cash flow
-7,201
-8,355
2,923
-8,905
-9,314